Echo Therapeutics (ECTE) Reports Q3 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Net loss applicable to common shareholders: 794.17K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net loss applicable to common shareholders: 794.17K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.16), versus ($0.21) reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
